2010 Deep Research Report on China Solar Grade Polysilcon Industry was professional and depth research report on global and China solar grade polysilicon industry.this report has firstly introduced polysilicon definition classification industry chain etc relation information. Then introduced polysilicon manufacturing technology and process (Siemens or FBR).At the same time, introduced key processes specifications and applications.

And then Summary statistics of Global and China major polysilicon manufacturers 2008-2014 solar grade (SG) and Electronic grade (EG) polysilicon capacity production supply demand (mainly according silicon crystalline solar cell demand and semiconductor wafer demand) shortage and polysilicon selling price cost profit profit margin and production value. And also introduced international 24 and China 30 major polysilicon companies basic information, 2008-2014 EG EG polysilicon capacity production price cost profit margin and production value etc details information and polysilicon project Siemens CVD reactor sources or Project design and construction services partners. and also introduced polysilicon materials cost, electricity cost, Depreciation cost,Labor cost etc polysilicon manufacturing cost and cost structure,finally, this report introduced 3000ton/year polysilicon project feasibility analysis and investment return analysis.also give related research conclusions and development trend analysis of China polysilicon industry.

In a word, it was a depth research report on Global and China polysilicon industry. And thanks to the support and assistance from polysilicon industry chain (polysilicon companies Solar wafer cell module companies raw materials Siemens CVD Reactors TCS STC-TCS system suppliers government related agencies etc) related experts and enterprises during QYResearch Team survey and interview.

To buy this report: 2010 Deep Research Report on China Solar Grade Polysilcon Industry

More Market Research Reports

Check our Company Profiles

Bharat Book Bureau
Email: sandhya@bharatbook.com
Tel: +91 22 27578668
Fax: +91 22 27579131

2010-2014 Deep Research Report on China Wind Power Converter Industry was professional and depth research report on China wind power converter industry. this report has firstly introduced wind power converter definition classification industry chain etc relation information. Then introduced wind power converter manufacturing technology and process.

And then Summary statistics of China 2009 Full-power Converter (direct drive wind turbine) Double-fed converter (Double-fed wind turbine) company production market share,2009-2014 China wind power converter demand and supply demand and shortage. then introduced 1.5MW full-power converter and double-fed converter price cost profit production value and profit margin etc details information. and also introduced China local or foreign 21 key converter manufacturers company basic information, full-power converter double-fed converter (1.5MW 3.0MW) etc converter capacity production price cost profit production value profit margin and their customers etc details information, finally, this report introduced 400units MW class wind power converter project feasibility analysis and investment return analysis.

Also give related research conclusions and development trend analysis of China wind power converter industry. In a word, it was a depth research report on China wind power converter industry. And thanks to the support and assistance from wind power converter industry chain (converter companies wind turbine companies IGBT etc suppliers government related agencies etc) related experts and enterprises during QYResearch Team survey and interview.

To buy this report: 2010-2014 Deep Research Report on China Wind Power Converter Industry

More Market Research Reports

Check our Company Profiles

Bharat Book Bureau
Email: sandhya@bharatbook.com
Tel: +91 22 27578668
Fax: +91 22 27579131

2010 Deep Research Report on Global and China Third Generation Solar Cell Industry was professional and depth research report on global and China Third Generation (3G) Solar Cell industry.this report has firstly introduced 3G solar cell definition efficiency industry chain etc relation information. Then introduced 3G solar cell classification R&D status and 3G solar cell layer structure, And then Summary statistics of Global and China major 3G solar cell manufacturers 3G solar cell cost efficiency technology and Global DSSC Organic Solar Cell Quantum Dot Solar Cell 2010-2015 Production Demand and Shortage, at the same time, introduced three type 3G solar cell 2010-2020 cost and efficiency forecast and 1G 2G 3G solar cell production comparison.

And also introduced global and China 43 major third generation solar cell companies basic information, 3G solar product information (such as cell technology materials cost efficiency product life commercial production date etc) .finally, this report introduced 3G solar cell (DSSC) manufacturing process, raw materials and equipments supply information and cost structure of 3G solar cell, also introduced global and China research labs list and China DSSC project Feasibility Analysis and give related research conclusions and development trend analysis of third generation solar cell industry.

In a word, it was a depth research report on Global and China third generation solar cell industry. And thanks to the support and assistance from third generation solar cell industry chain (third generation solar cell companies, raw materials or equipment suppliers and government related agencies etc) related experts and enterprises during QYResearch Team survey and interview.

To buy this report: 2010 Deep Research Report on Global and China Third Generation Solar Cell Industry

More Market Research Reports

Check our Company Profiles

Bharat Book Bureau
Email: sandhya@bharatbook.com
Tel: +91 22 27578668
Fax: +91 22 27579131

The Renub Research report titled “The World Diabetes Market, 2007-2025: An analysis of Diabetes Drug and Insulin Market” gives a detailed analysis on the global diabetes market. This report investigates the top 10 countries: diabetes prevalence, diabetes drug market and insulin market. It also provides a description of the sales and market share of top 10 brands in anti-obesity drug and diabetes drug market globally. This report talks about the prevalence of Impaired Glucose Tolerance (IGT) globally, 20 countries annual health expenditure on diabetes, death due to type 1 and type 2 diabetes globally.

Market Overview

In recent year’s diabetes drug market and insulin market has shown remarkable growth. This growth is mostly driven by increasing prevalence of diabetes globally and easily availability of insulin in other countries due to its access at an affordable price. The diabetes prevalence is increasing due to changing food habits in the western world leading to obesity.

As the prevalence of obesity and related diseases (diabetes) has increased, so have the sales of drugs to treat them. Top 9 brands of anti-obesity drugs have done sales of more than US$ 100 Million by November 2007 to October 2008. Whereas, top 8 diabetes drug made a sale of more than US$ 5 Billion from the period of October 2007 to October 2008.

Although the works are going on to make the oral-pills an alternative for insulin but at present none of the systems have mimics the physiology of insulin secretion. So it is expected that insulin market will keep on growing to reach US$ 15 Billion by 2012. In future Insulin demand will be driven by countries such as US, China, India, Brazil, Russia and Germany.

Countries Analyzed

World Top 10 diabetic populace countries performances on: diabetes prevalence, diabetes drugs market and insulin market (their past, present and future forecast) have been analyzed in this report. The countries covered in this repot are as follows: United States (US), China, India, Brazil, Russia, Germany, Pakistan, Mexico, Egypt and Japan.
Research Highlights

• By 2025 it is expected that India, China and US will be the first, second and third most diabetic populace country.
• In 2005 use of Non-U100 insulin was very popular in India, Ukraine and Egypt its use was more than 50 percent.
• Anti-obesity drug Meridia and Phentermine Hcl combined corner a market share of more than 65 percent globally from the period of November 2007 to October 2008.
• Anti-diabetic drug Actos (product of Takeda) control the highest market share of 40.5 percent globally from the period of October 2007 to October 2008.
• Diabetes drug Actos sale was highest it was more than twice the sale of its nearest competitor Januvia for the period of October 2007 to October 2008.
• Indian diabetic drug market is expected to be more than Rs. 3,200 Crore by 2010.
• Human insulin market in India has been increased to 30 percent in 2007 compared to 25 percent in 2003.
• In India delivery of insulin using cartridges and pen systems is less than 20 percent but it is growing by 35 percent annually.
• China insulin and analogue market grow by 55.8 percent in the year 2007 compared to 2006.
• Russia insulin market is expected to cross the mark of US$ 600 Million by 2010.
• In 2004 Mexico insulin market was just 1 percent of its total pharmaceutical market.

Key Players

Novo Nordisk A/S, Sanofi-Aventis, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Servier, Bayer AG, Merck & Co., Eli Lilly and Company, Amylin Pharmaceuticals, Inc., Merck KGaA

Data Sources

The information has been collected from various printable and non-pintable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, Government Agencies and Trade associations.

To know more and to buy a copy of the report “The World Diabetes Market, 2007-2025: An analysis of Diabetes Drug and Insulin Market” feel free to visit http://www.bharatbook.com or contact us at +91 22 27578668.

World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments published by Renub Research talks about the world vaccine market. This report gives the past, present scenario on the vaccines market and also forecast on future of vaccines market. Such as market size of Hepatitis B vaccines, Pneumococcal vaccines, Cervical Cancer vaccines etc. are there in the report. Forecast for the future market size of vaccine for diseases like Malaria, Ebola, Tuberculosis (TB), Japanese Encephalitis, West Nile, Typhoid etc. which are yet to be launched in the market have also been included in the report. The report also forecast on the sales of the key vaccines brands like Gardasil, Fluzone/Vaxigrip/Mutagrip, Prevnar, RotaTeq, Rotarix etc. Major companies’ vaccines sales data for the year 2007 and 2008 are also there in the report.

Market Overview

The vaccines landscape is very different now as compared to few years back. With increasing public awareness about preventive healthcare and increased spending by governments for the same has once again put spotlight on the vaccines. Quality of life is expected to increase markedly with introduction of newer vaccines covering more and more diseases. Due to this vaccines, which were perceived as low margin business before, have now emerged as one of the most lucrative segments in the pharmaceutical industry. Moreover with the success of a number of blockbuster products, the market place has changed dramatically. Pharma major’s today look upon vaccines as a driver for their future growth.

Already vaccines have become big business for pharmaceutical giants like GlaxoSmithKline, sanofi pasteur and Merck & Co.. For e.g. GSK Bio, GSK's vaccines arm, accounted for 8.4 percent of GSK's pharmaceutical turnover in 2006. And it is expected that by 2012 companies like GSK, Sanofi-aventis, Merck & Co., and Wyeth vaccines arm will fetch them more than 10 percent of sales from vaccine as a percentage of overall pharma sales.

Sector wise basic pediatrics share is declining as most of the vaccines in this sector are either off patent or newer and more effective vaccines have replaced them. Proprietary pediatrics and cancer pediatrics will define the future growth going forward. Vaccines like Prevnar (Pneumococcal vaccines), Gardasil (Cervical cancer vaccines) have crossed the sales of US$ 1 Billion by 2007. In fact Prevnar became the first vaccine to cross the US$ 2 Billion annual sales in 2007.

With the growth in international travel vaccine market of adult/travel sector is also going to grow further. Malaria vaccines, Typhoid Vaccines and Japanese Encephalitis Vaccines are expected to grow further in the market. Malaria vaccine which is expected to launch in 2010 or 2011, is forecasted to be worth US$ 419 Million market by 2025. Typhoid vaccine market for travelers is expected to grow with a CAGR of 4 percent from 2003 to 2014.

Ongoing spate of mergers and accquisition in pharma sector its effect and causes on the overall industry. Such as Pfizer taking over Wyeth would cement Pfizer’s position as the world’s leading drugmaker. Geographic segment wise China and India vaccine market will grow considerably in future and Japanese vaccine market has also started to open up further from regulatory and political barriers. Overall the worldwide vaccine market has registered revenue of US$ 21 Billion in 2008.

Report Forecast

• Worldwide Vaccine Market
• Influenza Market
• Adult/Travel Market
• Proprietary Pediatrics/Adolescent Market
• Enhanced Pediatrics Market
• Basic Pediatrics Market
• Major Vaccines Market (For complete list see heading no. 4 below in table of contents)
• Major Geographic Vaccine Markets
• Sales Forecast for Key Vaccine Brands (Cervarix, RotaTeq, Flu, Zostavax, ProQuad, Infanrix (DTP), Menactra, Rotarix, Gardasil, Prevnar, Fluzone/Vaxigrip/Mutagrip, 13-Valent Pneumococcal, Synflorix, Imvamune, H5N1 Influenza Vaccine, Hepatitis B vaccine).

Research Highlights

• M&A by big pharma like Pfizer and Merck and its effect in terms of consolidation in pharma industry.
• Collectively Europe & Asia Pacific accounts for the 60 percent of the Hepatitis B vaccine market.
• Public market share of malaria vaccine revenue increases from 43 percent in 2015 to 77 percent in 2025.
• Japanese encephalitis vaccine market is expected to cross the figure of US$ 400 Million by 2012.
• By 2015 it is expected that Cervical Cancer patients will be 320 Thousand worldwide.
• India and China vaccine market is expected to grow with a CAGR of 16 and 17.8 percent respectively from 2006 to 2013.
• Vaccines like Infanrix (DTP) of GSK and Flu vaccine of sanofi pasteur will have a market of more than US$ 1 Billion by 2010.
• Despite global slowdown vaccine sale of all major companies such as Merck, GSK, Sanofi Aventis has been increased in 2008 compared to 2007.
• 14 different vaccines have been analyzed in the report (for details refer heading no. 4 below in table of contents).

Data Sources

The information and data in this report has been collected from various printable and non-pintable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.

To know more and to buy a copy of the report “World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments” feel free to visit http://www.bharatbook.com or contact us at +91 22 27578668.

Renub Research report titled “India Electrical Equipment Sector: Analysis & Future Forecast” offers a comprehensive guide to the size and shape of the electrical market at global and India level. It provides the latest electrical equipment production data (2004-05 – 2008-09), allowing you to identify the sectors driving growth. This report also covers data for (2007-08 & 2008-09) of 27 major electrical equipments exports & imports of India. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, format trends or distribution issues. Forecasts to 2013 illustrate how the market is set to change.

India Electrical Equipment Production - Product Coverage:

LT Motors, HT Motors, LT Capacitors, HT Capacitors, Switch Fuse & Fuse Switch Unit, LT Circuit Breaker, HT Circuit Breaker, Surge Arrester, Voltage Transformer, Current Transformer, Power Transformer, Energy Meters, Motor Stamping, Transformer Laminations, Transmission Line Tower, Miniature Circuit Breaker, Power Cables

India Electrical Equipment - Product Coverage Exports & Imports:

Steeper, Micro, Wiper Motors etc., DC Motors & Generators, FHP Motors, AC Motors, Generating sets with Diesel Engines, Liquid Dielectric Transformers- up to 650 KVA, Liquid Dilectric Transformers-above 650 kVA, Power Capacitors, HV Breakers, LT Fuses-all Types, Air Circuit Breakers, Moulded case Circuit Breakers, Miniature Circuit Breakers, Other Automatic Circuit Breakers, MCC, PCC & Switchboard/Panels for voltage not exceeding 1,000 V, MCC, PCC & Switchboard/Panels for voltage exceeding 1,000 V, Halogen Lamps, Compact Flourecent Lamps, Mercury Vapour, Sodium Discharge, Metal Halid Gas Discharge Lamps, LV Cables, HV Cables, Electrical Insulators of Ceramics-Procelain disc/post/pin, Electrical Insulators of Other Material, Electricity Energy Meters, Measuring insurments like Ammeters, Voltmeters, Capacitance Meters, Transmission Line Towers

Market Overview

India’s vibrant economy needs matching improvements in the infrastructure. Power sector will play important role in the economic development and hence need focused attention. But due to global economic crisis India electrical equipment half yearly growth registered in 2008-09 is down to 8.57 percent from 14.6 percent of the previous financial year (2007-08). However, India posted a positive growth compared with global growth where the growth has been negative a fall of 2.2 percent in 2008 compared to 2007.

Ministry of Power - India has taken number of legislative and policy initiatives to expedite power sector development such as Rajiv Gandhi Gramin Vidyutikaran Yogna (RGGVY). All these initiatives provide loads of investment opportunities to FIIs and other investors. The power sector reforms if implemented as scheduled will create large business for power sector equipment manufacturers and service providers. In India electrical sector export in the past 3 years (2004-05 to 2007-08) has grown with much higher CAGR of 57.28 percent compared to 32.25 percent for the period of 1995-96 to 2007-08. We can expect a continuous handsome growth for this sector for at least next five years and it is expected to cross INR 400 Billion by 2013.

Research Highlights

• Due to financial crisis global electrical equipment market has fallen by 2.02 percent in 2008 compared to previous year 2007.
• In 2008 Power Cables and Switchgear together controls 60 percent of the market share in global electrical equipment market.
• India electrical sector exports have grown with a 40 percent in 2007-08 to compared previous year 2006-07.
• Due to economic slowdown India electrical sector has shown a decline of 6.04 percentage points for the half-yearly 2008-09 compared to half-year 2007-08.
• Despite India electrical sector negative growth Voltage transformers and Power transformers has shown a growth of 28.6 and 25.7 percent respectively for the year 2008-09 compared to 2007-08.

Key Players

This section provides the overview and key financials of prominent players in the “India Electrical Equipment Industry: Analysis & Future Forecast” such as, Bharat Heavy Electricals Limited (BHEL), Crompton Greaves Ltd., ABB Ltd. India , Alstom Limited India

Data Sources

Information and data in this report has been collected from various printable and non-printable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.

To know more and to buy a copy of the report “India Electrical Equipment Sector: Analysis & Future Forecast” feel free to visit http://www.bharatbook.com or contact us at +91 22 27578668.

Insulin Delivery Devices Market Analysis and Future Forecast published by Renub Research gives a detailed analysis on the global insulin market. The report analyses and forecast on market size of different insulin delivery devices i.e. global insulin pen market, insulin pump market, insulin syringe market and insulin jet injector market. The report investigates insulin delivery devices market on the country level as well. Countries covered in the report are: for Insulin pen market – US, Europe, India and Japan; Insulin pump market – US and India; Insulin syringe market – US and India; Insulin jet injector market – US.

After analyzing data from different sources we have come to conclusion that insulin pen is the most preferred mode of injecting insulin globally. Though the insulin syringes are still popular it is ceding market share rapidly to insulin pen and pump. Currently insulin pen leads the market segment but in the future insulin pump will dominate the market, as there is lot of R&D going on for improving it. Insulin pen are popular in Europe and Japan while insulin pumps are gaining popularity in US, fast replacing the dominance of insulin syringe in the market. Even developing countries like India are adapting the insulin pen for its growth going forward. Among future devices oral insulin and implantable insulin pump have bright future.

Key Questions Answered in this Report

• What is the present and future market size of insulin pen, insulin pump, insulin syringe and insulin jet injector globally?
• What is insulin delivery devices market in 2007 and 2014 for Europe?
• What is the present and future forecast of US, Europe and India insulin pen market?
• What is the market share of companies in global pump market?
• What is the present and future forecast of US insulin pump market?
• Which company will control the US pump market in future?
• What is oral insulin market of US?
• What is the future of insulin patch, oral insulin and implantable insulin pump?

Report Highlights

• Globally by 2007 insulin pen controls more than 50 percent of market share in insulin delivery devices market.
• In 2006 insulin pen market share in Europe and Japan was more than 85 percent.
• Global insulin pump and disposables market is expected to grow with a double digit figure.
• By 2009 companies Disetronic and MiniMed together are expected to control more than 70 percent of the insulin pump market globally.
• US insulin pen is forecasted to grow at a CAGR of 11.96 percent from 2006 to 2010.
• US insulin syringe market is expected to show a negative CAGR of -0.7 from 2007 to 2009.
• US insulin pump market is expected to grow with a CAGR of 11.8 percent from 2002 to 2009.
• European insulin pen market is expected to grow further but its market share is expected to decline from 89.7 percent in 2007 to 70.6 percent in 2014.

Key Company Profiles

This section provides business overview and key financial information of the companies listed:
Novo Nordisk A/S, Sanofi-Aventis, Becton, Dickinson and Company, GlaxoSmithKline plc, Amylin Pharmaceuticals, Inc., Merck & Co., Inc., Eli Lilly and Company.

Data Sources

Information and data in this report has been collected from various printable and non-pintable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.

To know more and to buy a copy of the report “Insulin Delivery Devices Market Analysis and Future Forecast” feel free to visit http://www.bharatbook.com or contact us at +91 22 27578668.

Renub Research report titled “India Tourism Market & Future Forecast (2009 – 2015)” report provides a detailed analysis of the present and future prospects of the Indian tourism industry. The report has been researched at source Globally and India specific, and features latest-available data covering Global tourist arrival and receipts, Global International and Outbound tourism, Top 10 spenders globally, Inbound and Outbound tourist arrivals and expenditure in India, Domestic tourist visits and expenditure in India, Foreign Direct Investment (FDI) in hotel and tourism sector from 2005 to 2009. Hotel industry income and revenue, Global and India – Inbound, Outbound tourist arrival and expenditure forecast till 2015, Buddhist tourism growth trends, Trends and regulatory changes, changes, Challenges affecting the Indian tourism sector.

Research Highlights

• International tourist arrival in India is expected to grow with a CAGR of 7.9% for the period spanning 2010-2015.
• Despite economic downturn Indian outbound tourist departure has been estimated to increase by 0.87 Million in 2008.
• Indian outbound tourist departure is expected to reach 20.5 Million by 2015.
• In 2008, top four (4) states captures more than 75% of total market share of Indian domestic tourist visits.
• Domestic tourist visits is expected to increase with a CAGR of 12.29% for the period spanning 2008-2015.
• In 2008, top three (3) countries contributed 40.15% share of the total international tourist arrival in India.
• Foreign Exchange Earnings growth rate has declined to single digit 9.5% in 2008 and in 2009 it further declined and shown a negative growth rate of (-3%).
• Indian tourism Foreign Exchange Earnings is expected to grow with a CAGR of 7.9% for the period spanning 2010-2015.
• In Indian union budget 2010 Indian government has given more than INR 1,000 Crore to Ministry of Tourism India
• In 2009 FDI investment in Indian hotel and tourism sector was more than US$ 550 Million.
• The number of cruise tourist arrivals in India is expected to jump by 233.33% by 2010 from the number of cruise tourist arrivals in 2007.
• Number of Buddhist tourist arrivals in India has doubled in 2009 from 2008
• Budget for Incredible India campaign increased by INR 62.3 Crore for 2010-11 from previous year 2009-10.
• The number of medical tourist arrivals in India is expected to increase by a CAGR of 24.6% from 2009 to 2013.
• India medical tourism market is expected to be more than US$ 2 Billion by 2013.

Key Players Analyzed

This section covers the key facts about the major players (tour operators, hotels and airline companies) currently operating in the Indian tourism industry. The key players analyzed in this section include: Tour Operators: Thomas Cook India Pvt. Ltd., Kuoni India Ltd., Cox & Kings India Ltd., Hotels & Resorts: Taj Hotels, The Oberoi Group, Hyatt Corporation, Flight Operators: Air India, Jet Airways

Data Sources

Information and data in this report has been collected from various printable and non-printable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.

To know more and to buy a copy of the report “India Tourism Market & Future Forecast (2009 – 2015)” feel free to visit http://www.bharatbook.com or contact us at +91 22 27578668.

“Singapore Travel & Tourism Market (2009 – 2015)” published by Renub Research provides an in-depth analysis of the present and future prospects of the Singapore travel and tourism industry. The report has been researched at source Globally and Singapore specific, and features latest-available data covering:

• Global tourist arrival and receipts
• International and Outbound tourism globally
• Top 10 spenders globally
• Inbound and Outbound tourist arrivals
• Expenditure in Singapore by top 10 countries
• Hotel industry - No. of hotels & rooms, revenue generation from hotels, Average Occupancy Rate, Average Room Rate & Revenue per Available Room data is available
• Singapore – Inbound, Outbound tourist arrival and expenditure forecast till 2015
• Sectors – Holiday, Business Travel & MICE Industry (Meetings, Incentives, Conventions, Exhibitions)
• Cruise Tourism, Formula One Grand Prix Race, and Casino Tourism have been analyzed in the report.

Research Highlights

• Globally International tourist arrivals reached 922.4 Million, up from 904.3 Million in 2007, representing a growth of 2%.
• It is estimated that by 2020 international tourist’s arrival will cross the mark of 1.5 Billion tourist’s arrivals globally.
• Singapore Inbound tourist arrivals have crossed the 10 Million mark by the end of 2008.
• It is expected that the Inbound tourist arrival in Singapore will increase with a CAGR value of around 10.18% for the period spanning from 2009-2015.
• It is forecasted that Singapore tourism receipts will increase with a CAGR value 15.71 % for the period spanning 2009-2015.
• Business Meetings, Incentives, Conventions, Exhibitions are the second highest region for travelers to visit Singapore from 2006 to 2008 and it’s increasing its share rapidly.
• Singapore hotel room revenue has grown with a CAGR of 15.5% for the period of 2004 to 2008.
• Internet is the most preferred medium to gather information by tourist, In 2008 more than 50% tourists gathered information from internet.
• Singapore cruise passenger is expected to cross the figure of 1 Million by 2015.
• Formula One Grand Prix Race is attracting lots of tourists to Singapore and generated more than US$ 100 Million of Tourism Receipts in 2008.
• Casino tourism is going to be another major revenue earner for Singapore tourism.

Key Players Analyzed

This section covers the key facts about the major players (airlines, hotels and tour operators) currently operating in the Indian tourism industry. The key players analyzed in this section include - Airlines: Cathay Pacific Airways Ltd, Garuda Indonesia, Singapore Airlines Ltd, Thai Airways International Ltd, Hotels: Meritus Mandarin, Singapore, The Pan Pacific Hotel, Singapore, Tour Operators: Prime Travel & Tour, WTS Travel & Tours

Data Sources

Information and data in this report has been collected from various printable and non-printable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.

To know more and to buy a copy of the report “Singapore Travel & Tourism Market (2009 – 2015)” feel free to visit http://www.bharatbook.com or contact us at +91 22 27578668.
 

Asia medical tourism industry has been growing with a double digit CAGR and expected to reach US$ 8.5 Billion by 2013. Thailand and India vie with each other for the medical tourism crown. Thailand’s prices are a bit higher on average than India’s, with the main advantages being a better overall tourist experience and more bundling of services. In 2008 Thailand has treated the highest number of international patients compared to any other Asian countries. But its market share of Asia medical tourist arrivals and medical tourism market is declining year on year is a matter of concern.

India advantages are that it is the cheapest of any of the world medical tourism destinations, while being the equal of the other major destinations in terms of quality of staff, equipment and healthcare procedures. With many brand new state of the art hospitals and western trained doctors it is easy to see why it is a leader in medical tourism. In 2008 India market shares in Asia medical tourist arrivals was 18.7 percent and it is expected to rise further to nearly 25 percent by 2013.

However, these two major players are getting tough competitions from other Asian countries like Philippines, Singapore, Malaysia and South Korea. All these have government-backed medical tourism programs and are trying to catch up fast. Singapore is planning to be developed into a leading health care destination in Asia with its medical tourism market steady growth of 11.9 percent over the past few years (2004 to 2008).

In comparison to this South Korea is planning to develop an island into a healthcare hub with all the latest healthcare facilities by 2011. The island will be a two-hour flight from five major Asian cities Seoul, Beijing, Shanghai, Hong Kong and Tokyo. Malaysia is concentrating on neighboring countries like Indonesia Singapore for its growth going forward. The international patient arrivals to Malaysia are expected to grow with a CAGR of 29.27 percent for the period of 2009 to 2013.

“Asia Medical Tourism Analysis (2008 – 2013)” provides detailed analysis about the past, present and future outlook of medical tourism in Asia. Six Asian countries (India, Malaysia, Philippines, Thailand, Singapore, and South Korea) markets have been covered in this report. Each country markets has been analyzed from the point of medical tourist arrivals, medical tourism market, cost of medical treatment, patient perceptions, driving forces of that market, and roadblocks (challenges) to the market. This report provides valuable information to clients looking to venture into these markets and helps them to advise strategies while going for an investment in these markets. This report will help Investment Bankers, Research Analyst, Management Consultants, Researchers, Wealth Managers etc. to have access to the latest trends and recent developments in medical tourism industry.

Research Highlights

• India offers the cheapest medical treatment in comparison to other Asian medical destination.
• India is forecasted to treat the second highest number of medical tourist in 2013 after Thailand.
• Introduction of cosmetic surgery tax in 2009 by Indian government puts India on the disadvantages position compared to other Asian countries.
• In 2007 more than 70 percent of medical tourists visiting Malaysia were of Indonesian origin.
• Medical tourist arrival in Singapore was 15 percent less in 2007 compared to 2006.
• Thailand is forecasted to have the highest number of medical tourist among other Asian countries by 2013.
• By 2011, South Korea is planning to develop an island for medical tourism with an investment of US$ 315 Million having all types of healthcare facilities. The island is only a two-hour flight from five major cities Seoul, Beijing, Shanghai, Hong Kong and Tokyo.
• South Korea has opened one-stop service center for medical travelers like establishing of information booths and medical information website in five languages.
• South Korea government has allowed foreign investors (individual and institutional) to operate hospitals in the country’s free economic zones (FEZs).

Key Players

This section provides the overview and key financials of prominent players in the Asian medical tourism markets, such as Apollo, Bumrungrad, Raffles and Parkway Health.

Data Sources

Information and data in this report has been collected from various printable and non-printable sources like Magazines, Newspapers, Trade Journals, White papers, Online paid databases, News websites Government Agencies and Trade associations.

To know more and to buy a copy of the report “Asia Medical Tourism Analysis (2008 – 2013)” feel free to visit http://www.bharatbook.com or contact us at +91 22 27578668.